Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 08/09/2026			5-day change	1st Jan Change
12.77 ^MXN	-3.40%		-2.96%	-28.62%

09-01	Genomma Lab Internacional, S.A.B. de C.V. Enters Into MXN 1.0 Billion Long-Term Credit Facility With Banamex	CI
07-23	Genomma Lab Internacional, S.A.B. de C.V., Q2 2026 Earnings Call, Jul 23, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	12,451	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-28.74%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	17,138	16,099	15,581
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-22.95%	-6.06%	-3.22%
P/E	14.9x	12x	13.1x	11.7x	11.1x	5.91x	6.2x	5.51x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	0.88x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.2x	-1.3x	0.4x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.67x	0.66x	0.62x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	0.93x	0.85x	0.77x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	3.95x	3.67x	3.32x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.3x	4.05x	3.65x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	17.7x	7.86x	6.98x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	5.65%	12.7%	14.3%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8335	1.071	1.441
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	6.53%	8.39%	11.3%
EPS ²	1.44	1.41	1.08	2.14	1.61	2.161	2.058	2.32
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	38.6%	52%	62.1%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	18,512	18,989	20,213
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,342	4,382	4,693
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,987	3,979	4,269
Net income ¹	1,451	1,397	1,031	2,137	1,607	2,086	2,122	2,370
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,687	3,648	3,130
Reference price ²	21.48	16.94	14.16	25.13	17.89	12.77	12.77	12.77
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,033	-	-
Announcement Date	23/02/22	22/02/23	21/02/24	26/02/25	25/02/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	6.12x	0.95x	4.05x	6.3%	762M
ELI LILLY AND COMPANY	32.72x	11.9x	24.26x	0.6%	1,024B
JOHNSON & JOHNSON	30.62x	-	-	1.95%	663B
ABBVIE INC.	32.73x	7.6x	15.8x	2.67%	453B
ROCHE HOLDING AG	19.22x	4.69x	11.6x	2.83%	349B
NOVARTIS AG	22.02x	5.68x	14.1x	2.82%	295B
ASTRAZENECA PLC	20.97x	4.3x	12.3x	2.05%	253B
AMGEN INC.	27.66x	7.14x	13.16x	2.31%	236B
NOVO NORDISK A/S	13.33x	4.82x	10.06x	3.78%	206B
GILEAD SCIENCES, INC.	-46.14x	6.65x	25.95x	2.18%	187B
Average	15.92x	5.97x	14.59x	2.75%	366.81B
Weighted average by Cap.	23.94x	7.97x	17.77x	1.96%